Inhibitory Effects of Polygonum cuspidatum on the Epstein-Barr Virus Lytic Cycle

被引:0
|
作者
Yiu, Ching-Yi [2 ]
Chen, Shih-Ying [3 ]
Huang, Ching-Wen [4 ]
Yeh, Dong-Bor [4 ]
Lin, Tsuey-Pin [1 ]
机构
[1] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Otolaryngol, Tainan, Taiwan
[3] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan
[4] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan
关键词
Polygonum cuspidatum; antiviral activity; EBV; LYMPHOBLASTOID CELL-LINES; RESVERATROL INHIBITION; GROWTH-FACTOR; REPLICATION; TRANSCRIPTION; ACTIVATION; INFECTION; MACROPHAGES; NUCLEOSIDE; BUTYRATE;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Polygonum cuspidatum is widely used as a medicinal herb in Asia. In this study, we examined the ethanolic extract of Polygonum cuspidatum roots (PcE) for their capacity to inhibit the EBV lytic cycle. The cell viability was determined by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] method. The expression of Epstein-Barr virus (EBV) lytic proteins was analyzed by flow cytometric assay. Real-time quantitative PCR was used to measure the EBV virion production. Transient transfection analysis was subsequently performed to assess the transcription of lytic genes, including BRLF1 and BZLF1. Results showed that the PcE inhibited the transcription of EBV immediate early genes, the expression of EBV lytic proteins, including Rta, Zta, and EA-D and reduced the production of virus particles, showing that PcE is useful for preventing the proliferation of the virus.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 50 条
  • [21] Pharmacologic induction of Epstein-Barr virus lytic cycle: Strategies for tumor therapy
    Moore, SM
    Ambinder, RF
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 101 - 101
  • [22] Epstein-Barr virus lytic infection in lymphocytes and the persistence of the virus
    Tao, Q
    BLOOD, 1997, 90 (05) : 2114 - 2115
  • [23] MYC Controls the Epstein-Barr Virus Lytic Switch
    Guo, Rui
    Jiang, Chang
    Zhang, Yuchen
    Govande, Apurva
    Trudeau, Stephen J.
    Chen, Fang
    Fry, Christopher J.
    Puri, Rishi
    Wolinsky, Emma
    Schineller, Molly
    Frost, Thomas C.
    Gebre, Makda
    Zhao, Bo
    Giulino-Roth, Lisa
    Doench, John G.
    Teng, Mingxiang
    Gewurz, Benjamin E.
    MOLECULAR CELL, 2020, 78 (04) : 653 - +
  • [24] Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation
    Sacau, EP
    Estévez-Braun, A
    Ravelo, AG
    Ferro, EA
    Tokuda, H
    Mukainaka, T
    Nishino, H
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 483 - 488
  • [25] Latent and lytic Epstein-Barr virus replication strategies
    Tsurumi, T
    Fujita, M
    Kudoh, A
    REVIEWS IN MEDICAL VIROLOGY, 2005, 15 (01) : 3 - 15
  • [26] Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation
    Koyama, J
    Morita, I
    Tagahara, K
    Ogata, M
    Mukainaka, T
    Tokuda, H
    Nishino, H
    CANCER LETTERS, 2001, 170 (01) : 15 - 18
  • [27] Inhibition of the Ethanolic Extract from Polygonum cuspidatum Root on the Functions of Epstein-Barr Virus Latent Membrane Protein 1
    Yiu, Ching-Yi
    Chen, Shih-Ying
    Chen, Yi-Pin
    Lin, Tsuey-Pin
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2013, 21 (01) : 20 - 26
  • [28] Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle
    Gradoville, L
    Kwa, D
    El-Guindy, A
    Miller, G
    JOURNAL OF VIROLOGY, 2002, 76 (11) : 5612 - 5626
  • [29] Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference
    Chang, Y
    Chang, SS
    Lee, HH
    Doong, SL
    Takada, K
    Tsai, CH
    JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 1371 - 1379
  • [30] Epstein-Barr virus lytic cycle involvement in diffuse large B cell lymphoma
    Cohen, Melina
    Vistarop, Aldana Georgina
    Huaman, Fuad
    Narbaitz, Marina
    Metrebian, Fernanda
    De Matteo, Elena
    Preciado, Maria Victoria
    Chabay, Paola Andrea
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 98 - 103